Lenvatinib‐associated hemoperitoneum in a patient with primary angiosarcoma of the breast

Abstract

Key Clinical Message We highlight the risk of lenvatinib drug toxicity when high‐risk anatomic regions are affected by angiosarcoma.

Keywords

• angiosarcoma
• embolization
• hemoperitoneum
• lenvatinib